Navigating the Shifting Tides of Wall Street: The Current State and Future of IPOs
The IPO market, a barometer of economic health and innovation, has recently stirred with significant activity, highlighted by Shein’s US IPO filing and the anticipated [more…]
Supreme Court Deliberates on Purdue Pharma’s Contentious Bankruptcy Settlement
The U.S. Supreme Court recently entered the heated debate surrounding Purdue Pharma’s bankruptcy settlement, a pivotal moment in the ongoing opioid crisis gripping the nation. [more…]
Q+A: Why it’s the perfect time for Marmota to return to its uranium roots
The nuclear renaissance is shining ever brighter as spot prices touch US$80/lb. For uranium explorers like Marmota (ASX:MEU), the prolonged downturn following the Fukushima incident [more…]
MoneyTalks: This educational stock could profit from the return of international students to Australia
Academics Australasia could benefit from the return of international students MaxiPARTS’s valuation looks attractive at this level The return of international students Taylor Collison [more…]
What’s the best way to hoard gold during a crisis?
Retail interest in gold/silver bars and coins has soared to near record highs in 2023 Bars and coins are the most direct way to own [more…]
Saxo’s Annual Outrageous Predictions: Which ones came close to hitting the bullseye over the years?
A country agrees to ban all meat production was a stretch but meat emerges as big aspect of addressing climate change 2017 prediction of huge [more…]
FREE WHELAN: The price of the US 10-year controls the world and it’s already on holiday
In this Stockhead series, investment manager James Whelan, managing director Barclay Pearce Capital Asset Management, offers his insights on the key investment themes and trends in domestic [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to Tuesday, 5 December – a date on the calendar that has become a staple for fans of the great [more…]
Closing Bell: ASX wins friends and influences portfolios after Monday outperformance
The ASX benchmark has monstered Monday 9 of 11 sectors in the green Small caps led by Compumedics Australia’s share market put in a powerful [more…]
In Case You Missed It: Home sleep test nabs FDA approval
Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing [more…]
